Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial
Cowan, R.A., Scarisbrick, J.J., Zinzani, P.L., Nicolay, J.P., Sokol, L., Pinter‐Brown, L., Quaglino, P., Iversen, L., Dummer, R., Musiek, A., Foss, F., Ito, T., Rosen, J‐P., Medley, M.C.
Published in Journal of the European Academy of Dermatology and Venereology (01.11.2021)
Published in Journal of the European Academy of Dermatology and Venereology (01.11.2021)
Get full text
Journal Article
Outcomes of auto-SCT for lymphoma in subjects aged 70 years and over
Andorsky, D J, Cohen, M, Naeim, A, Pinter-Brown, L
Published in Bone marrow transplantation (Basingstoke) (01.09.2011)
Published in Bone marrow transplantation (Basingstoke) (01.09.2011)
Get full text
Journal Article
P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS
Zinzani, P. L., Zain, J., Mead, M., Casulo, C., Jacobsen, E. D., Gritti, G., Pinter‐Brown, L., Isutzu, K., Cohan, D., Daugherty, M., Brammer, J. E., Mehta‐Shah, N., Pro, B., Horwitz, S. M.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: outcomes by baseline histology
Mehta‐Shah, N., Jacobsen, E. D., Zinzani, P. L., Zain, J., Mead, M., Casulo, C., Gritti, G., Pinter‐Brown, L., Izutsu, K., Waters, S., Brammer, J. E., Pro, B., Horwitz, S. M.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Phase 1 trial of KT‐333, a STAT3 degrader, in patients with relapsed or refractory lymphomas, large granular lymphocytic leukemia and solid tumors
Smith, S., Olszewski, A., Starodub, A. N., Stevens, D. A., Feldman, T., Porcu, P., Epstein‐Peterson, Z., Huen, A., Pinter‐Brown, L., Mattour, A., Perea, R., Gollerkeri, A., Dey, J., Klaus, C., Agarwal, S., Gollob, J., Shastri, A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
P721 Faecal microbiota analysis with body composition and nutritional habits simultaneously amongst Crohn’s disease patients
Bálint, A, Bacsur, P, Resál, T, Jójárt, B, Gyuris, Z, Jaksa, G, Pintér, L, Takács, B, Pál, S, Gácser, A, Szántó, K J, Rutka, M, Bor, R, Fábián, A, Farkas, K, Maléth, J, Szepes, Z, Molnár, T
Published in Journal of Crohn's and colitis (21.01.2022)
Published in Journal of Crohn's and colitis (21.01.2022)
Get full text
Journal Article
First clinical use of a novel neurovascular access and neuroprotection system demonstrates complete absence of emboli by transcranial Doppler during carotid artery stenting
Pinter, L, Ribo, M, Roberts, T, Chou, T M, Kolvenbach, R R
Published in Journal of cardiovascular surgery (01.12.2011)
Get more information
Published in Journal of cardiovascular surgery (01.12.2011)
Journal Article
FINAL DATA FROM THE PHASE 3 ALCANZA STUDY: BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN PATIENTS (PTS) WITH CD30‐POSITIVE (CD30+) CUTANEOUS T‐CELL LYMPHOMA (CTCL)
Horwitz, S.M., Scarisbrick, J., Prince, H.M., Whittaker, S., Duvic, M., Kim, Y.H., Quaglino, P., Zinzani, P.L., Bechter, O., Eradat, H., Pinter‐Brown, L., Akilov, O., Geskin, L., Sanches, J., Ortiz‐Romero, P., Lisano, J., Brown, L., Palanca‐Wessels, M.C., Gautam, A., Bunn, V., Little, M., Dummer, R.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
Microbiological features of Staphylococcus schleiferi subsp. coagulans, isolated from dogs and possible misidentification with other canine coagulase-positive staphylococci
Zdovc, I, Ocepek, M, Pirs, T, Krt, B, Pinter, L
Published in Journal of veterinary medicine. Series B (01.12.2004)
Published in Journal of veterinary medicine. Series B (01.12.2004)
Get full text
Journal Article
Utility of (18)fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma
Horwitz, S. M., Coiffier, Bertrand, Foss, F, Prince, H. M., Sokol, L, Greenwood, M, Caballero, Dolores, Morschhauser, Franck, Pinter-Brown, L, Iyer, S. P., Shustov, A, Nichols, J, Balser, J, Balser, B., Pro, B
Published in Annals of oncology (01.04.2015)
Published in Annals of oncology (01.04.2015)
Get full text
Journal Article